Literature DB >> 23864392

The new oral anticoagulants: results of clinical trials and practical applications.

Jack Ansell.   

Abstract

Mesh:

Substances:

Year:  2013        PMID: 23864392     DOI: 10.1007/s11239-013-0961-5

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN: 0929-5305            Impact factor:   2.300


× No keyword cloud information.
  5 in total

1.  The discovery of dicumarol and its sequels.

Authors:  K P LINK
Journal:  Circulation       Date:  1959-01       Impact factor: 29.690

Review 2.  New oral anticoagulants should not be used as first-line agents to prevent thromboembolism in patients with atrial fibrillation.

Authors:  Jack Ansell
Journal:  Circulation       Date:  2012-01-03       Impact factor: 29.690

Review 3.  New antithrombotic drugs: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Jeffrey I Weitz; John W Eikelboom; Meyer Michel Samama
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

4.  Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

Authors:  Jack Ansell; Jack Hirsh; Elaine Hylek; Alan Jacobson; Mark Crowther; Gualtiero Palareti
Journal:  Chest       Date:  2008-06       Impact factor: 9.410

5.  Use and effectiveness of warfarin in Medicare beneficiaries with atrial fibrillation.

Authors:  Elena Birman-Deych; Martha J Radford; David S Nilasena; Brian F Gage
Journal:  Stroke       Date:  2006-03-09       Impact factor: 7.914

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.